🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether 5-azacitidine in combinat...
Status
Completed
Location
Sidney Kimmel Cancer Center @ Johns Hopkins
Start Date
2012-02
Trial ID
NCT01537744
Treatments Being Tested
The investigator is testing the addition of venetoclax to 5-azacitidine and...
Status
Recruiting
Location
Children's Wisconsin
Start Date
2023-03-31
Trial ID
NCT05317403
Treatments Being Tested
This is a clinical study aiming to evaluate the safety, pharmacokinetics, p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-10
Trial ID
NCT07303660
Treatments Being Tested
This is an open-label, multicenter, dose-escalation Phase 1/1b study in pat...
Status
Completed
Location
Cedars Sinai
Start Date
2015-09
Trial ID
NCT02543879
Treatments Being Tested
The primary objectives of this study are: * To confirm the safety and tole...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2017-09-08
Trial ID
NCT03248479
Treatments Being Tested
This is an open-label, Phase 1 study to determine the safety, tolerability,...
Status
Recruiting
Location
Monash Health
Start Date
2024-06-04
Trial ID
NCT06372717
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of the...
Status
Completed
Location
University of Rochester
Start Date
2010-01
Trial ID
NCT00861874
Treatments Being Tested
The purpose of this study is to see whether giving azacitidine before each ...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2011-06
Trial ID
NCT01386346
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT03030612
This is a dose escalation followed by dose expansion study of TL32711 in co...
Status
Completed
Location
Palo Verde Hematology Oncology
Start Date
2013-06
Trial ID
NCT01828346
Treatments Being Tested